$100+ Billion spent on myriad of acquisitions across Pharma and Biotech industries in H1 2018
Lloyd Price
JULY 5, 2018
For many biotech companies, mergers and acquisitions have become a cornerstone in building a robust pipeline that can ensure positive growth for years to come. Celgene wasn’t the only company in January to make a big M&A splash. This was the biggest deal for GSK since Emma Walmsley took over the reins of the company last year.
40 
Let's personalize your content